Design and rationale for the Myocardial Stem Cell Administration After Acute Myocardial Infarction (MYSTAR) Study: a multicenter, prospective, randomized, single-blind trial comparing early and late intracoronary or combined (percutaneous intramyocardial and intracoronary) administration of nonselected autologous bone marrow cells to patients after acute myocardial infarction.
Am Heart J
; 153(2): 212.e1-7, 2007 Feb.
Article
em En
| MEDLINE
| ID: mdl-17239678
Buscar no Google
Base de dados:
MEDLINE
Assunto principal:
Transplante de Medula Óssea
/
Infarto do Miocárdio
Idioma:
En
Ano de publicação:
2007
Tipo de documento:
Article
País de afiliação:
Áustria